Global Pharmaceutical CDMO Solution Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Pharmaceutical CDMO Solution market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Pharmaceutical CDMO Solution market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical CDMO Solution market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO Solution market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO Solution market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO Solution market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical CDMO Solution
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical CDMO Solution market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific) and Siegfried AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical CDMO Solution market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Pharmaceutical CDMO Solution product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical CDMO Solution, with revenue, gross margin and global market share of Pharmaceutical CDMO Solution from 2018 to 2023.
Chapter 3, the Pharmaceutical CDMO Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical CDMO Solution market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical CDMO Solution.
Chapter 13, to describe Pharmaceutical CDMO Solution research findings and conclusion.
This report is a detailed and comprehensive analysis for global Pharmaceutical CDMO Solution market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical CDMO Solution market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO Solution market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO Solution market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO Solution market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical CDMO Solution
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical CDMO Solution market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recipharm AB, Lonza Group, Catalent, Patheon (Thermo Fisher Scientific) and Siegfried AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical CDMO Solution market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Active Pharmaceutical Ingredient (API) Manufacturing
- Finished Dosage Formulation (FDF) Development and Manufacturing
- Secondary Packaging
- Others
- Innovative Medicine
- Patented Drug
- Patent Expired Drug
- Others
- Recipharm AB
- Lonza Group
- Catalent
- Patheon (Thermo Fisher Scientific)
- Siegfried AG
- SGS Quay Pharmaceuticals
- Curia
- Societal CDMO
- Aenova Group
- Eurofins CDMO
- Piramal Group
- WuXi AppTec Group
- Fareva
- Strides Pharma Science
- Famar Health Care Service
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Pharmaceutical CDMO Solution product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical CDMO Solution, with revenue, gross margin and global market share of Pharmaceutical CDMO Solution from 2018 to 2023.
Chapter 3, the Pharmaceutical CDMO Solution competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical CDMO Solution market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical CDMO Solution.
Chapter 13, to describe Pharmaceutical CDMO Solution research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Pharmaceutical CDMO Solution
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical CDMO Solution by Type
1.3.1 Overview: Global Pharmaceutical CDMO Solution Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharmaceutical CDMO Solution Consumption Value Market Share by Type in 2022
1.3.3 Active Pharmaceutical Ingredient (API) Manufacturing
1.3.4 Finished Dosage Formulation (FDF) Development and Manufacturing
1.3.5 Secondary Packaging
1.3.6 Others
1.4 Global Pharmaceutical CDMO Solution Market by Application
1.4.1 Overview: Global Pharmaceutical CDMO Solution Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Innovative Medicine
1.4.3 Patented Drug
1.4.4 Patent Expired Drug
1.4.5 Others
1.5 Global Pharmaceutical CDMO Solution Market Size & Forecast
1.6 Global Pharmaceutical CDMO Solution Market Size and Forecast by Region
1.6.1 Global Pharmaceutical CDMO Solution Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharmaceutical CDMO Solution Market Size by Region, (2018-2029)
1.6.3 North America Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
1.6.4 Europe Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
1.6.6 South America Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Recipharm AB
2.1.1 Recipharm AB Details
2.1.2 Recipharm AB Major Business
2.1.3 Recipharm AB Pharmaceutical CDMO Solution Product and Solutions
2.1.4 Recipharm AB Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Recipharm AB Recent Developments and Future Plans
2.2 Lonza Group
2.2.1 Lonza Group Details
2.2.2 Lonza Group Major Business
2.2.3 Lonza Group Pharmaceutical CDMO Solution Product and Solutions
2.2.4 Lonza Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Lonza Group Recent Developments and Future Plans
2.3 Catalent
2.3.1 Catalent Details
2.3.2 Catalent Major Business
2.3.3 Catalent Pharmaceutical CDMO Solution Product and Solutions
2.3.4 Catalent Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Catalent Recent Developments and Future Plans
2.4 Patheon (Thermo Fisher Scientific)
2.4.1 Patheon (Thermo Fisher Scientific) Details
2.4.2 Patheon (Thermo Fisher Scientific) Major Business
2.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product and Solutions
2.4.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Patheon (Thermo Fisher Scientific) Recent Developments and Future Plans
2.5 Siegfried AG
2.5.1 Siegfried AG Details
2.5.2 Siegfried AG Major Business
2.5.3 Siegfried AG Pharmaceutical CDMO Solution Product and Solutions
2.5.4 Siegfried AG Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Siegfried AG Recent Developments and Future Plans
2.6 SGS Quay Pharmaceuticals
2.6.1 SGS Quay Pharmaceuticals Details
2.6.2 SGS Quay Pharmaceuticals Major Business
2.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product and Solutions
2.6.4 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SGS Quay Pharmaceuticals Recent Developments and Future Plans
2.7 Curia
2.7.1 Curia Details
2.7.2 Curia Major Business
2.7.3 Curia Pharmaceutical CDMO Solution Product and Solutions
2.7.4 Curia Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Curia Recent Developments and Future Plans
2.8 Societal CDMO
2.8.1 Societal CDMO Details
2.8.2 Societal CDMO Major Business
2.8.3 Societal CDMO Pharmaceutical CDMO Solution Product and Solutions
2.8.4 Societal CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Societal CDMO Recent Developments and Future Plans
2.9 Aenova Group
2.9.1 Aenova Group Details
2.9.2 Aenova Group Major Business
2.9.3 Aenova Group Pharmaceutical CDMO Solution Product and Solutions
2.9.4 Aenova Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aenova Group Recent Developments and Future Plans
2.10 Eurofins CDMO
2.10.1 Eurofins CDMO Details
2.10.2 Eurofins CDMO Major Business
2.10.3 Eurofins CDMO Pharmaceutical CDMO Solution Product and Solutions
2.10.4 Eurofins CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eurofins CDMO Recent Developments and Future Plans
2.11 Piramal Group
2.11.1 Piramal Group Details
2.11.2 Piramal Group Major Business
2.11.3 Piramal Group Pharmaceutical CDMO Solution Product and Solutions
2.11.4 Piramal Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Piramal Group Recent Developments and Future Plans
2.12 WuXi AppTec Group
2.12.1 WuXi AppTec Group Details
2.12.2 WuXi AppTec Group Major Business
2.12.3 WuXi AppTec Group Pharmaceutical CDMO Solution Product and Solutions
2.12.4 WuXi AppTec Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 WuXi AppTec Group Recent Developments and Future Plans
2.13 Fareva
2.13.1 Fareva Details
2.13.2 Fareva Major Business
2.13.3 Fareva Pharmaceutical CDMO Solution Product and Solutions
2.13.4 Fareva Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Fareva Recent Developments and Future Plans
2.14 Strides Pharma Science
2.14.1 Strides Pharma Science Details
2.14.2 Strides Pharma Science Major Business
2.14.3 Strides Pharma Science Pharmaceutical CDMO Solution Product and Solutions
2.14.4 Strides Pharma Science Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Strides Pharma Science Recent Developments and Future Plans
2.15 Famar Health Care Service
2.15.1 Famar Health Care Service Details
2.15.2 Famar Health Care Service Major Business
2.15.3 Famar Health Care Service Pharmaceutical CDMO Solution Product and Solutions
2.15.4 Famar Health Care Service Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Famar Health Care Service Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Pharmaceutical CDMO Solution Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharmaceutical CDMO Solution by Company Revenue
3.2.2 Top 3 Pharmaceutical CDMO Solution Players Market Share in 2022
3.2.3 Top 6 Pharmaceutical CDMO Solution Players Market Share in 2022
3.3 Pharmaceutical CDMO Solution Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical CDMO Solution Market: Region Footprint
3.3.2 Pharmaceutical CDMO Solution Market: Company Product Type Footprint
3.3.3 Pharmaceutical CDMO Solution Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Pharmaceutical CDMO Solution Consumption Value and Market Share by Type (2018-2023)
4.2 Global Pharmaceutical CDMO Solution Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2023)
5.2 Global Pharmaceutical CDMO Solution Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
6.2 North America Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
6.3 North America Pharmaceutical CDMO Solution Market Size by Country
6.3.1 North America Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
6.3.2 United States Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
6.3.3 Canada Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
7.2 Europe Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
7.3 Europe Pharmaceutical CDMO Solution Market Size by Country
7.3.1 Europe Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
7.3.2 Germany Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
7.3.3 France Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
7.3.5 Russia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
7.3.6 Italy Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Region (2018-2029)
8.3.2 China Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8.3.3 Japan Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8.3.5 India Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8.3.7 Australia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
9.2 South America Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
9.3 South America Pharmaceutical CDMO Solution Market Size by Country
9.3.1 South America Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
10.3.4 UAE Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Pharmaceutical CDMO Solution Market Drivers
11.2 Pharmaceutical CDMO Solution Market Restraints
11.3 Pharmaceutical CDMO Solution Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Pharmaceutical CDMO Solution Industry Chain
12.2 Pharmaceutical CDMO Solution Upstream Analysis
12.3 Pharmaceutical CDMO Solution Midstream Analysis
12.4 Pharmaceutical CDMO Solution Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Pharmaceutical CDMO Solution
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical CDMO Solution by Type
1.3.1 Overview: Global Pharmaceutical CDMO Solution Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharmaceutical CDMO Solution Consumption Value Market Share by Type in 2022
1.3.3 Active Pharmaceutical Ingredient (API) Manufacturing
1.3.4 Finished Dosage Formulation (FDF) Development and Manufacturing
1.3.5 Secondary Packaging
1.3.6 Others
1.4 Global Pharmaceutical CDMO Solution Market by Application
1.4.1 Overview: Global Pharmaceutical CDMO Solution Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Innovative Medicine
1.4.3 Patented Drug
1.4.4 Patent Expired Drug
1.4.5 Others
1.5 Global Pharmaceutical CDMO Solution Market Size & Forecast
1.6 Global Pharmaceutical CDMO Solution Market Size and Forecast by Region
1.6.1 Global Pharmaceutical CDMO Solution Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharmaceutical CDMO Solution Market Size by Region, (2018-2029)
1.6.3 North America Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
1.6.4 Europe Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
1.6.6 South America Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharmaceutical CDMO Solution Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Recipharm AB
2.1.1 Recipharm AB Details
2.1.2 Recipharm AB Major Business
2.1.3 Recipharm AB Pharmaceutical CDMO Solution Product and Solutions
2.1.4 Recipharm AB Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Recipharm AB Recent Developments and Future Plans
2.2 Lonza Group
2.2.1 Lonza Group Details
2.2.2 Lonza Group Major Business
2.2.3 Lonza Group Pharmaceutical CDMO Solution Product and Solutions
2.2.4 Lonza Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Lonza Group Recent Developments and Future Plans
2.3 Catalent
2.3.1 Catalent Details
2.3.2 Catalent Major Business
2.3.3 Catalent Pharmaceutical CDMO Solution Product and Solutions
2.3.4 Catalent Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Catalent Recent Developments and Future Plans
2.4 Patheon (Thermo Fisher Scientific)
2.4.1 Patheon (Thermo Fisher Scientific) Details
2.4.2 Patheon (Thermo Fisher Scientific) Major Business
2.4.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product and Solutions
2.4.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Patheon (Thermo Fisher Scientific) Recent Developments and Future Plans
2.5 Siegfried AG
2.5.1 Siegfried AG Details
2.5.2 Siegfried AG Major Business
2.5.3 Siegfried AG Pharmaceutical CDMO Solution Product and Solutions
2.5.4 Siegfried AG Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Siegfried AG Recent Developments and Future Plans
2.6 SGS Quay Pharmaceuticals
2.6.1 SGS Quay Pharmaceuticals Details
2.6.2 SGS Quay Pharmaceuticals Major Business
2.6.3 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product and Solutions
2.6.4 SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SGS Quay Pharmaceuticals Recent Developments and Future Plans
2.7 Curia
2.7.1 Curia Details
2.7.2 Curia Major Business
2.7.3 Curia Pharmaceutical CDMO Solution Product and Solutions
2.7.4 Curia Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Curia Recent Developments and Future Plans
2.8 Societal CDMO
2.8.1 Societal CDMO Details
2.8.2 Societal CDMO Major Business
2.8.3 Societal CDMO Pharmaceutical CDMO Solution Product and Solutions
2.8.4 Societal CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Societal CDMO Recent Developments and Future Plans
2.9 Aenova Group
2.9.1 Aenova Group Details
2.9.2 Aenova Group Major Business
2.9.3 Aenova Group Pharmaceutical CDMO Solution Product and Solutions
2.9.4 Aenova Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aenova Group Recent Developments and Future Plans
2.10 Eurofins CDMO
2.10.1 Eurofins CDMO Details
2.10.2 Eurofins CDMO Major Business
2.10.3 Eurofins CDMO Pharmaceutical CDMO Solution Product and Solutions
2.10.4 Eurofins CDMO Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eurofins CDMO Recent Developments and Future Plans
2.11 Piramal Group
2.11.1 Piramal Group Details
2.11.2 Piramal Group Major Business
2.11.3 Piramal Group Pharmaceutical CDMO Solution Product and Solutions
2.11.4 Piramal Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Piramal Group Recent Developments and Future Plans
2.12 WuXi AppTec Group
2.12.1 WuXi AppTec Group Details
2.12.2 WuXi AppTec Group Major Business
2.12.3 WuXi AppTec Group Pharmaceutical CDMO Solution Product and Solutions
2.12.4 WuXi AppTec Group Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 WuXi AppTec Group Recent Developments and Future Plans
2.13 Fareva
2.13.1 Fareva Details
2.13.2 Fareva Major Business
2.13.3 Fareva Pharmaceutical CDMO Solution Product and Solutions
2.13.4 Fareva Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Fareva Recent Developments and Future Plans
2.14 Strides Pharma Science
2.14.1 Strides Pharma Science Details
2.14.2 Strides Pharma Science Major Business
2.14.3 Strides Pharma Science Pharmaceutical CDMO Solution Product and Solutions
2.14.4 Strides Pharma Science Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Strides Pharma Science Recent Developments and Future Plans
2.15 Famar Health Care Service
2.15.1 Famar Health Care Service Details
2.15.2 Famar Health Care Service Major Business
2.15.3 Famar Health Care Service Pharmaceutical CDMO Solution Product and Solutions
2.15.4 Famar Health Care Service Pharmaceutical CDMO Solution Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Famar Health Care Service Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Pharmaceutical CDMO Solution Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharmaceutical CDMO Solution by Company Revenue
3.2.2 Top 3 Pharmaceutical CDMO Solution Players Market Share in 2022
3.2.3 Top 6 Pharmaceutical CDMO Solution Players Market Share in 2022
3.3 Pharmaceutical CDMO Solution Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical CDMO Solution Market: Region Footprint
3.3.2 Pharmaceutical CDMO Solution Market: Company Product Type Footprint
3.3.3 Pharmaceutical CDMO Solution Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Pharmaceutical CDMO Solution Consumption Value and Market Share by Type (2018-2023)
4.2 Global Pharmaceutical CDMO Solution Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2023)
5.2 Global Pharmaceutical CDMO Solution Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
6.2 North America Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
6.3 North America Pharmaceutical CDMO Solution Market Size by Country
6.3.1 North America Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
6.3.2 United States Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
6.3.3 Canada Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
7.2 Europe Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
7.3 Europe Pharmaceutical CDMO Solution Market Size by Country
7.3.1 Europe Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
7.3.2 Germany Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
7.3.3 France Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
7.3.5 Russia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
7.3.6 Italy Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Pharmaceutical CDMO Solution Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Region (2018-2029)
8.3.2 China Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8.3.3 Japan Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8.3.5 India Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
8.3.7 Australia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
9.2 South America Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
9.3 South America Pharmaceutical CDMO Solution Market Size by Country
9.3.1 South America Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Pharmaceutical CDMO Solution Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
10.3.4 UAE Pharmaceutical CDMO Solution Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Pharmaceutical CDMO Solution Market Drivers
11.2 Pharmaceutical CDMO Solution Market Restraints
11.3 Pharmaceutical CDMO Solution Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Pharmaceutical CDMO Solution Industry Chain
12.2 Pharmaceutical CDMO Solution Upstream Analysis
12.3 Pharmaceutical CDMO Solution Midstream Analysis
12.4 Pharmaceutical CDMO Solution Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Pharmaceutical CDMO Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical CDMO Solution Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Pharmaceutical CDMO Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Pharmaceutical CDMO Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Recipharm AB Company Information, Head Office, and Major Competitors
Table 6. Recipharm AB Major Business
Table 7. Recipharm AB Pharmaceutical CDMO Solution Product and Solutions
Table 8. Recipharm AB Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Recipharm AB Recent Developments and Future Plans
Table 10. Lonza Group Company Information, Head Office, and Major Competitors
Table 11. Lonza Group Major Business
Table 12. Lonza Group Pharmaceutical CDMO Solution Product and Solutions
Table 13. Lonza Group Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Lonza Group Recent Developments and Future Plans
Table 15. Catalent Company Information, Head Office, and Major Competitors
Table 16. Catalent Major Business
Table 17. Catalent Pharmaceutical CDMO Solution Product and Solutions
Table 18. Catalent Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Catalent Recent Developments and Future Plans
Table 20. Patheon (Thermo Fisher Scientific) Company Information, Head Office, and Major Competitors
Table 21. Patheon (Thermo Fisher Scientific) Major Business
Table 22. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product and Solutions
Table 23. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Patheon (Thermo Fisher Scientific) Recent Developments and Future Plans
Table 25. Siegfried AG Company Information, Head Office, and Major Competitors
Table 26. Siegfried AG Major Business
Table 27. Siegfried AG Pharmaceutical CDMO Solution Product and Solutions
Table 28. Siegfried AG Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Siegfried AG Recent Developments and Future Plans
Table 30. SGS Quay Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 31. SGS Quay Pharmaceuticals Major Business
Table 32. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product and Solutions
Table 33. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. SGS Quay Pharmaceuticals Recent Developments and Future Plans
Table 35. Curia Company Information, Head Office, and Major Competitors
Table 36. Curia Major Business
Table 37. Curia Pharmaceutical CDMO Solution Product and Solutions
Table 38. Curia Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Curia Recent Developments and Future Plans
Table 40. Societal CDMO Company Information, Head Office, and Major Competitors
Table 41. Societal CDMO Major Business
Table 42. Societal CDMO Pharmaceutical CDMO Solution Product and Solutions
Table 43. Societal CDMO Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Societal CDMO Recent Developments and Future Plans
Table 45. Aenova Group Company Information, Head Office, and Major Competitors
Table 46. Aenova Group Major Business
Table 47. Aenova Group Pharmaceutical CDMO Solution Product and Solutions
Table 48. Aenova Group Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Aenova Group Recent Developments and Future Plans
Table 50. Eurofins CDMO Company Information, Head Office, and Major Competitors
Table 51. Eurofins CDMO Major Business
Table 52. Eurofins CDMO Pharmaceutical CDMO Solution Product and Solutions
Table 53. Eurofins CDMO Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Eurofins CDMO Recent Developments and Future Plans
Table 55. Piramal Group Company Information, Head Office, and Major Competitors
Table 56. Piramal Group Major Business
Table 57. Piramal Group Pharmaceutical CDMO Solution Product and Solutions
Table 58. Piramal Group Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Piramal Group Recent Developments and Future Plans
Table 60. WuXi AppTec Group Company Information, Head Office, and Major Competitors
Table 61. WuXi AppTec Group Major Business
Table 62. WuXi AppTec Group Pharmaceutical CDMO Solution Product and Solutions
Table 63. WuXi AppTec Group Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. WuXi AppTec Group Recent Developments and Future Plans
Table 65. Fareva Company Information, Head Office, and Major Competitors
Table 66. Fareva Major Business
Table 67. Fareva Pharmaceutical CDMO Solution Product and Solutions
Table 68. Fareva Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Fareva Recent Developments and Future Plans
Table 70. Strides Pharma Science Company Information, Head Office, and Major Competitors
Table 71. Strides Pharma Science Major Business
Table 72. Strides Pharma Science Pharmaceutical CDMO Solution Product and Solutions
Table 73. Strides Pharma Science Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Strides Pharma Science Recent Developments and Future Plans
Table 75. Famar Health Care Service Company Information, Head Office, and Major Competitors
Table 76. Famar Health Care Service Major Business
Table 77. Famar Health Care Service Pharmaceutical CDMO Solution Product and Solutions
Table 78. Famar Health Care Service Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Famar Health Care Service Recent Developments and Future Plans
Table 80. Global Pharmaceutical CDMO Solution Revenue (USD Million) by Players (2018-2023)
Table 81. Global Pharmaceutical CDMO Solution Revenue Share by Players (2018-2023)
Table 82. Breakdown of Pharmaceutical CDMO Solution by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Pharmaceutical CDMO Solution, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Pharmaceutical CDMO Solution Players
Table 85. Pharmaceutical CDMO Solution Market: Company Product Type Footprint
Table 86. Pharmaceutical CDMO Solution Market: Company Product Application Footprint
Table 87. Pharmaceutical CDMO Solution New Market Entrants and Barriers to Market Entry
Table 88. Pharmaceutical CDMO Solution Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Pharmaceutical CDMO Solution Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Pharmaceutical CDMO Solution Consumption Value Share by Type (2018-2023)
Table 91. Global Pharmaceutical CDMO Solution Consumption Value Forecast by Type (2024-2029)
Table 92. Global Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023)
Table 93. Global Pharmaceutical CDMO Solution Consumption Value Forecast by Application (2024-2029)
Table 94. North America Pharmaceutical CDMO Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Pharmaceutical CDMO Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Pharmaceutical CDMO Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Pharmaceutical CDMO Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Pharmaceutical CDMO Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Pharmaceutical CDMO Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Pharmaceutical CDMO Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Pharmaceutical CDMO Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Pharmaceutical CDMO Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Pharmaceutical CDMO Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Pharmaceutical CDMO Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Pharmaceutical CDMO Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Pharmaceutical CDMO Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Pharmaceutical CDMO Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Pharmaceutical CDMO Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Pharmaceutical CDMO Solution Raw Material
Table 125. Key Suppliers of Pharmaceutical CDMO Solution Raw Materials
Table 1. Global Pharmaceutical CDMO Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical CDMO Solution Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Pharmaceutical CDMO Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Pharmaceutical CDMO Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Recipharm AB Company Information, Head Office, and Major Competitors
Table 6. Recipharm AB Major Business
Table 7. Recipharm AB Pharmaceutical CDMO Solution Product and Solutions
Table 8. Recipharm AB Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Recipharm AB Recent Developments and Future Plans
Table 10. Lonza Group Company Information, Head Office, and Major Competitors
Table 11. Lonza Group Major Business
Table 12. Lonza Group Pharmaceutical CDMO Solution Product and Solutions
Table 13. Lonza Group Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Lonza Group Recent Developments and Future Plans
Table 15. Catalent Company Information, Head Office, and Major Competitors
Table 16. Catalent Major Business
Table 17. Catalent Pharmaceutical CDMO Solution Product and Solutions
Table 18. Catalent Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Catalent Recent Developments and Future Plans
Table 20. Patheon (Thermo Fisher Scientific) Company Information, Head Office, and Major Competitors
Table 21. Patheon (Thermo Fisher Scientific) Major Business
Table 22. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Product and Solutions
Table 23. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Patheon (Thermo Fisher Scientific) Recent Developments and Future Plans
Table 25. Siegfried AG Company Information, Head Office, and Major Competitors
Table 26. Siegfried AG Major Business
Table 27. Siegfried AG Pharmaceutical CDMO Solution Product and Solutions
Table 28. Siegfried AG Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Siegfried AG Recent Developments and Future Plans
Table 30. SGS Quay Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 31. SGS Quay Pharmaceuticals Major Business
Table 32. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Product and Solutions
Table 33. SGS Quay Pharmaceuticals Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. SGS Quay Pharmaceuticals Recent Developments and Future Plans
Table 35. Curia Company Information, Head Office, and Major Competitors
Table 36. Curia Major Business
Table 37. Curia Pharmaceutical CDMO Solution Product and Solutions
Table 38. Curia Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Curia Recent Developments and Future Plans
Table 40. Societal CDMO Company Information, Head Office, and Major Competitors
Table 41. Societal CDMO Major Business
Table 42. Societal CDMO Pharmaceutical CDMO Solution Product and Solutions
Table 43. Societal CDMO Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Societal CDMO Recent Developments and Future Plans
Table 45. Aenova Group Company Information, Head Office, and Major Competitors
Table 46. Aenova Group Major Business
Table 47. Aenova Group Pharmaceutical CDMO Solution Product and Solutions
Table 48. Aenova Group Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Aenova Group Recent Developments and Future Plans
Table 50. Eurofins CDMO Company Information, Head Office, and Major Competitors
Table 51. Eurofins CDMO Major Business
Table 52. Eurofins CDMO Pharmaceutical CDMO Solution Product and Solutions
Table 53. Eurofins CDMO Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Eurofins CDMO Recent Developments and Future Plans
Table 55. Piramal Group Company Information, Head Office, and Major Competitors
Table 56. Piramal Group Major Business
Table 57. Piramal Group Pharmaceutical CDMO Solution Product and Solutions
Table 58. Piramal Group Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Piramal Group Recent Developments and Future Plans
Table 60. WuXi AppTec Group Company Information, Head Office, and Major Competitors
Table 61. WuXi AppTec Group Major Business
Table 62. WuXi AppTec Group Pharmaceutical CDMO Solution Product and Solutions
Table 63. WuXi AppTec Group Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. WuXi AppTec Group Recent Developments and Future Plans
Table 65. Fareva Company Information, Head Office, and Major Competitors
Table 66. Fareva Major Business
Table 67. Fareva Pharmaceutical CDMO Solution Product and Solutions
Table 68. Fareva Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Fareva Recent Developments and Future Plans
Table 70. Strides Pharma Science Company Information, Head Office, and Major Competitors
Table 71. Strides Pharma Science Major Business
Table 72. Strides Pharma Science Pharmaceutical CDMO Solution Product and Solutions
Table 73. Strides Pharma Science Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Strides Pharma Science Recent Developments and Future Plans
Table 75. Famar Health Care Service Company Information, Head Office, and Major Competitors
Table 76. Famar Health Care Service Major Business
Table 77. Famar Health Care Service Pharmaceutical CDMO Solution Product and Solutions
Table 78. Famar Health Care Service Pharmaceutical CDMO Solution Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Famar Health Care Service Recent Developments and Future Plans
Table 80. Global Pharmaceutical CDMO Solution Revenue (USD Million) by Players (2018-2023)
Table 81. Global Pharmaceutical CDMO Solution Revenue Share by Players (2018-2023)
Table 82. Breakdown of Pharmaceutical CDMO Solution by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Pharmaceutical CDMO Solution, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Pharmaceutical CDMO Solution Players
Table 85. Pharmaceutical CDMO Solution Market: Company Product Type Footprint
Table 86. Pharmaceutical CDMO Solution Market: Company Product Application Footprint
Table 87. Pharmaceutical CDMO Solution New Market Entrants and Barriers to Market Entry
Table 88. Pharmaceutical CDMO Solution Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Pharmaceutical CDMO Solution Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Pharmaceutical CDMO Solution Consumption Value Share by Type (2018-2023)
Table 91. Global Pharmaceutical CDMO Solution Consumption Value Forecast by Type (2024-2029)
Table 92. Global Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023)
Table 93. Global Pharmaceutical CDMO Solution Consumption Value Forecast by Application (2024-2029)
Table 94. North America Pharmaceutical CDMO Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Pharmaceutical CDMO Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Pharmaceutical CDMO Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Pharmaceutical CDMO Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Pharmaceutical CDMO Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Pharmaceutical CDMO Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Pharmaceutical CDMO Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Pharmaceutical CDMO Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Pharmaceutical CDMO Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Pharmaceutical CDMO Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Pharmaceutical CDMO Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Pharmaceutical CDMO Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Pharmaceutical CDMO Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Pharmaceutical CDMO Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Pharmaceutical CDMO Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Pharmaceutical CDMO Solution Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Pharmaceutical CDMO Solution Raw Material
Table 125. Key Suppliers of Pharmaceutical CDMO Solution Raw Materials
LIST OF FIGURES
s
Figure 1. Pharmaceutical CDMO Solution Picture
Figure 2. Global Pharmaceutical CDMO Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical CDMO Solution Consumption Value Market Share by Type in 2022
Figure 4. Active Pharmaceutical Ingredient (API) Manufacturing
Figure 5. Finished Dosage Formulation (FDF) Development and Manufacturing
Figure 6. Secondary Packaging
Figure 7. Others
Figure 8. Global Pharmaceutical CDMO Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Pharmaceutical CDMO Solution Consumption Value Market Share by Application in 2022
Figure 10. Innovative Medicine Picture
Figure 11. Patented Drug Picture
Figure 12. Patent Expired Drug Picture
Figure 13. Others Picture
Figure 14. Global Pharmaceutical CDMO Solution Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Pharmaceutical CDMO Solution Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Pharmaceutical CDMO Solution Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Pharmaceutical CDMO Solution Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Pharmaceutical CDMO Solution Consumption Value Market Share by Region in 2022
Figure 19. North America Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Pharmaceutical CDMO Solution Revenue Share by Players in 2022
Figure 25. Pharmaceutical CDMO Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Pharmaceutical CDMO Solution Market Share in 2022
Figure 27. Global Top 6 Players Pharmaceutical CDMO Solution Market Share in 2022
Figure 28. Global Pharmaceutical CDMO Solution Consumption Value Share by Type (2018-2023)
Figure 29. Global Pharmaceutical CDMO Solution Market Share Forecast by Type (2024-2029)
Figure 30. Global Pharmaceutical CDMO Solution Consumption Value Share by Application (2018-2023)
Figure 31. Global Pharmaceutical CDMO Solution Market Share Forecast by Application (2024-2029)
Figure 32. North America Pharmaceutical CDMO Solution Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Pharmaceutical CDMO Solution Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Pharmaceutical CDMO Solution Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Pharmaceutical CDMO Solution Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 42. France Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value Market Share by Region (2018-2029)
Figure 49. China Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 52. India Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Pharmaceutical CDMO Solution Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Pharmaceutical CDMO Solution Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Pharmaceutical CDMO Solution Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Pharmaceutical CDMO Solution Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 66. Pharmaceutical CDMO Solution Market Drivers
Figure 67. Pharmaceutical CDMO Solution Market Restraints
Figure 68. Pharmaceutical CDMO Solution Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Pharmaceutical CDMO Solution in 2022
Figure 71. Manufacturing Process Analysis of Pharmaceutical CDMO Solution
Figure 72. Pharmaceutical CDMO Solution Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
s
Figure 1. Pharmaceutical CDMO Solution Picture
Figure 2. Global Pharmaceutical CDMO Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical CDMO Solution Consumption Value Market Share by Type in 2022
Figure 4. Active Pharmaceutical Ingredient (API) Manufacturing
Figure 5. Finished Dosage Formulation (FDF) Development and Manufacturing
Figure 6. Secondary Packaging
Figure 7. Others
Figure 8. Global Pharmaceutical CDMO Solution Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Pharmaceutical CDMO Solution Consumption Value Market Share by Application in 2022
Figure 10. Innovative Medicine Picture
Figure 11. Patented Drug Picture
Figure 12. Patent Expired Drug Picture
Figure 13. Others Picture
Figure 14. Global Pharmaceutical CDMO Solution Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Pharmaceutical CDMO Solution Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Pharmaceutical CDMO Solution Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Pharmaceutical CDMO Solution Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Pharmaceutical CDMO Solution Consumption Value Market Share by Region in 2022
Figure 19. North America Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Pharmaceutical CDMO Solution Revenue Share by Players in 2022
Figure 25. Pharmaceutical CDMO Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Pharmaceutical CDMO Solution Market Share in 2022
Figure 27. Global Top 6 Players Pharmaceutical CDMO Solution Market Share in 2022
Figure 28. Global Pharmaceutical CDMO Solution Consumption Value Share by Type (2018-2023)
Figure 29. Global Pharmaceutical CDMO Solution Market Share Forecast by Type (2024-2029)
Figure 30. Global Pharmaceutical CDMO Solution Consumption Value Share by Application (2018-2023)
Figure 31. Global Pharmaceutical CDMO Solution Market Share Forecast by Application (2024-2029)
Figure 32. North America Pharmaceutical CDMO Solution Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Pharmaceutical CDMO Solution Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Pharmaceutical CDMO Solution Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Pharmaceutical CDMO Solution Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 42. France Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Pharmaceutical CDMO Solution Consumption Value Market Share by Region (2018-2029)
Figure 49. China Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 52. India Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Pharmaceutical CDMO Solution Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Pharmaceutical CDMO Solution Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Pharmaceutical CDMO Solution Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Pharmaceutical CDMO Solution Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Pharmaceutical CDMO Solution Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Pharmaceutical CDMO Solution Consumption Value (2018-2029) & (USD Million)
Figure 66. Pharmaceutical CDMO Solution Market Drivers
Figure 67. Pharmaceutical CDMO Solution Market Restraints
Figure 68. Pharmaceutical CDMO Solution Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Pharmaceutical CDMO Solution in 2022
Figure 71. Manufacturing Process Analysis of Pharmaceutical CDMO Solution
Figure 72. Pharmaceutical CDMO Solution Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
